A Phase 1b study of MEDI4920 in Subjects with Adult-onset Rheumatoid Arthritis

Trial Identifier: D5100C00002
Sponsor: MedImmune, LLC
Collaborator:
Study transferred to VelaBio
NCTID:: NCT02780388
Start Date: May 2016
Primary Completion Date: May 2018
Study Completion Date: August 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Polish Translation
Spanish Translation

Trial Locations

Country Location
Poland Bialystok, Poland, 15-897
Poland Bydgoszcz, Poland, 85-168
Poland Poznan, Poland, 60-856
Poland Warszawa, Poland, 02-106
Poland Warszawa Targowek, Poland, 03-291
United States of America, AL Anniston, AL, United States of America, 36207
United States of America, AZ Phoenix, AZ, United States of America, 85023
United States of America, FL Debary, FL, United States of America, 32713
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL miami, FL, United States of America, 33134
United States of America, FL Miami Lakes, FL, United States of America, 33014
United States of America, FL South Miami, FL, United States of America, 33143
United States of America, OH Cincinnati, OH, United States of America, 45242
United States of America, PA Duncansville, PA, United States of America, 16635
United States of America, TX Mesquite, TX, United States of America, 75150